Stock Events

Stock Events

Delic 

C$0.005000
1
+C$0.00+0%Friday 13:30

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
102,900
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-530.6%Profit Margin
Unprofitable
2020
2021
1.89MRevenue
-10.04MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap1.6B
Compass Pathways operates in the psychedelic medicine sector, focusing on psilocybin therapy for mental health issues, directly competing with Delic's focus on psychedelic wellness.
AtaiBeckley
ATAI
Mkt Cap2.73B
ATAI Life Sciences works on developing psychedelic and non-psychedelic compounds for mental health disorders, competing in the same new sector as Delic.
GH Research
GHRS
Mkt Cap1.43B
GH Research focuses on developing 5-MeO-DMT therapies for treatment-resistant depression, a direct competitor in the psychedelic treatment space.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness focuses on psychedelic production and therapy, including wellness clinics, directly competing with Delic's business model.
Revive Therapeutics
RVVTF
Mkt Cap9.15M
Revive Therapeutics is involved in the research and development of psychedelic medicines, including treatments for mental health disorders, competing in the same emerging sector as Delic.
Noveris Health Sciences
MYCOF
Mkt Cap42.74M
Mydecine Innovations Group focuses on developing and commercializing psychedelic medicines, directly competing with Delic in the psychedelic therapy market.

About

Delic Holdings Corp., headquartered in Vancouver, Canada, delivers a variety of medical and therapeutic services across the United States and Canada. The company operates several digital and event-based initiatives aimed at promoting public discourse and education regarding psychedelic culture. These include "The Delic," a creative platform for community engagement; "Meet Delic," which organizes events exploring subjects such as safety, mental wellness, human optimization, and psychedelic medicine; "Reality Sandwich," an extensive online educational resource boasting over 10,000 articles, guides, news, and cultural content; and "Delic Radio," a podcast featuring expert discussions on various facets of the psychedelic domain, including science, policy, and current affairs. Furthermore, Delic Holdings Corp. actively develops intellectual property through research and development in both cannabis and psychedelics. The company also owns and operates numerous ketamine infusion treatment clinics.
Show More
CEO
Kevin Nicholson
Employees
116
Country
Canada
ISIN
CA24689D1096
WKN
000A3C4LT

Listings

CN
CA
DELC.CN
OTC Link
US
DELCF

0 Comments

Share your thoughts

FAQs

What is Delic stock price today?▼
The current price of DELC.CN is C$0.01 CAD — it has increased by +0% in the past 24 hours. Watch Delic stock price performance more closely on the chart.
What is Delic stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Canadian Securities Exchange exchange Delic stocks are traded under the ticker DELC.CN.
What is Delic market cap?▼
Today Delic has the market capitalization of 102,900
What is Delic revenue for the last year?▼
Delic revenue for the last year amounts to 1.89M CAD.
What is Delic net income for the last year?▼
DELC.CN net income for the last year is -10.04M CAD.
How many employees does Delic have?▼
As of November 3, 2026, the company has 116 employees.
In which sector is Delic located?▼
Delic operates in the Communication sector.
When did Delic complete a stock split?▼
Delic has not had any recent stock splits.
Where is Delic headquartered?▼
Delic is headquartered in Vancouver, Canada.